important distinctionmcb.berkeley.edu/courses/mcb140/syllabus/urnov_lectures/...1 1 mcb 140 12-4-06...

17
1 MCB 140 12-4-06 Nosce te ipsum: the human genome Part II: genetics, diagnostics, and gene therapy of inherited disease 2 MCB 140 12-4-06 Important distinction 1. “Monogenic disorders” – human diseases whose etiology can in some more or less linear fashion be traced to a single-locus genetic lesion. 2. Diseases with a “genetic component” or a “genetic predisposition” – disorders that mankind is known to be genetically polymorphic for (in terms of susceptibility) at multiple loci. 3. All other disease (that may or may not be transcription based). 1. Phenomena affecting ploidy (e.g., aneuploidies such as Down, Edwards, Turner, Klinefelter). 2. Phenomena affecting chromosome structure (e.g., translocations in leukemia). 3. Phenomena affecting single loci (genes or relatively small chromosomal segments). 3 MCB 140 12-4-06 Archibald Garrod (1902) Higher frequency of children with alkaptonuria (urine turns dark on standing and alkalinization) from consanguineous marriages. Why? “There is no reason to suppose that mere consanguinity of parents can originate such a condition as alkaptonuria in their offspring, and we must rather seek an explanation in some peculiarity of the parents, which may remain latent for generations… It has recently been pointed out by Bateson that the law of heredity discovered by Mendel offers a reasonable account of such phenomena. …”” http://www.esp.org/foundations/genetics/classical/ag-02.pdf Garrod (1902) Lancet 2: 116. 4 MCB 140 12-4-06 Garrod (1902) Lancet 2: 116.

Upload: others

Post on 25-Mar-2020

4 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Important distinctionmcb.berkeley.edu/courses/mcb140/Syllabus/urnov_lectures/...1 1 MCB 140 12-4-06 Nosce te ipsum: the human genome Part II: genetics, diagnostics, and gene therapy

1

1M

CB

140

12-

4-06

Nos

ce te

ipsu

m:

the

hum

an g

enom

eP

art I

I: ge

netic

s, d

iagn

ostic

s, a

nd

gene

ther

apy

of in

herit

ed d

isea

se

2M

CB

140

12-

4-06

Impo

rtant

dis

tinct

ion

1.“M

onog

enic

dis

orde

rs” –

hum

an d

isea

ses

who

se

etio

logy

can

in s

ome

mor

e or

less

line

ar fa

shio

n be

tra

ced

to a

sin

gle-

locu

s ge

netic

lesi

on.

2.D

isea

ses

with

a “g

enet

ic

com

pone

nt” o

r a “g

enet

ic

pred

ispo

sitio

n” –

diso

rder

s th

at m

anki

nd is

kno

wn

to b

e ge

netic

ally

pol

ymor

phic

for

(in te

rms

of s

usce

ptib

ility

) at

mul

tiple

loci

.3.

All

othe

r dis

ease

(tha

t may

or

may

not

be

trans

crip

tion

base

d).

1.P

heno

men

a af

fect

ing

ploi

dy (e

.g.,

aneu

ploi

dies

suc

h as

D

own,

Edw

ards

, Tur

ner,

Klin

efel

ter)

.2.

Phe

nom

ena

affe

ctin

g ch

rom

osom

e st

ruct

ure

(e.g

., tra

nslo

catio

ns in

le

ukem

ia).

3.P

heno

men

a af

fect

ing

sing

le lo

ci (g

enes

or

rela

tivel

y sm

all

chro

mos

omal

se

gmen

ts).

3M

CB

140

12-

4-06

Arc

hiba

ld G

arro

d (1

902)

Hig

her f

requ

ency

of c

hild

ren

with

alk

apto

nuria

(urin

e tu

rns

dark

on

stan

ding

and

alk

alin

izat

ion)

from

con

sang

uine

ous

mar

riage

s.W

hy?

“The

re is

no

reas

on to

sup

pose

that

mer

e co

nsan

guin

ity o

f pa

rent

s ca

n or

igin

ate

such

a c

ondi

tion

as a

lkap

tonu

ria in

th

eir o

ffspr

ing,

and

we

mus

t rat

her s

eek

an e

xpla

natio

n in

so

me

pecu

liarit

y of

the

pare

nts,

whi

ch m

ay re

mai

n la

tent

fo

r gen

erat

ions

… It

has

rece

ntly

bee

n po

inte

d ou

t by

Bat

eson

that

the

law

of h

ered

ity d

isco

vere

d by

Men

del

offe

rs a

reas

onab

le a

ccou

nt o

f suc

h ph

enom

ena.

…””

http

://w

ww

.esp

.org

/foun

datio

ns/g

enet

ics/

clas

sica

l/ag-

02.p

df

Gar

rod

(190

2) L

ance

t 2: 1

16.

4M

CB

140

12-

4-06

Gar

rod

(190

2) L

ance

t 2: 1

16.

Page 2: Important distinctionmcb.berkeley.edu/courses/mcb140/Syllabus/urnov_lectures/...1 1 MCB 140 12-4-06 Nosce te ipsum: the human genome Part II: genetics, diagnostics, and gene therapy

2

5M

CB

140

12-

4-06

Sic

kle-

cell

anem

ia –

a br

ief h

isto

ry“In

the

wes

tern

lite

ratu

re, t

he fi

rst

desc

riptio

n of

sic

kle

cell

dise

ase

was

by

a C

hica

go p

hysi

cian

, Ja

mes

B. H

erric

k, w

ho n

oted

in

1910

that

a p

atie

nt o

f his

from

th

e W

est I

ndie

s ha

d an

ane

mia

ch

arac

teriz

ed b

y un

usua

l red

ce

lls th

at w

ere

sick

le-s

hape

d.”

By

1923

, it w

as re

aliz

ed th

e co

nditi

on is

her

edita

ry.

In 1

949,

Nee

l rea

lized

that

pa

tient

s w

ith S

CA

are

ho

moz

ygou

s, a

nd h

eter

ozyg

ous

carri

ers

have

a m

uch

mild

er

cond

ition

(sic

kle

cell

trait)

.

6M

CB

140

12-

4-06

Sic

kle

cell

anem

iaN

IH:

“Sic

kle

cell

anem

ia is

the

mos

t co

mm

on in

herit

ed b

lood

di

sord

er in

the

Uni

ted

Sta

tes,

af

fect

ing

abou

t 72,

000

Am

eric

ans

or 1

in 5

00 A

frica

n A

mer

ican

s. S

CA

is

char

acte

rized

by

epis

odes

of

pain

, chr

onic

hem

olyt

ic a

nem

ia

and

seve

re in

fect

ions

, usu

ally

be

ginn

ing

in e

arly

chi

ldho

od.”

7M

CB

140

12-

4-06

Linu

s P

aulin

g, 1

949:

HbS

has

diff

eren

t cha

rge!

!

8M

CB

140

12-

4-06

V. I

ngra

m, N

atur

e 19

56“O

n [th

e ex

istin

g] e

vide

nce

alon

e, it

is n

ot p

ossi

ble

to

deci

de w

heth

er th

e di

ffere

nce

betw

een

the

prot

eins

, w

hich

is in

any

eve

nt s

mal

l, lie

s in

the

amin

o-ac

id

sequ

ence

s of

the

poly

pept

ide

chai

ns, o

r whe

ther

it li

es

in th

e fo

ldin

g of

thes

e ch

ains

lead

ing

to th

e m

aski

ng o

f so

me

amin

o-ac

id s

ide

chai

ns.”

Exp

erim

ent:

1.D

iges

t Hb

A a

nd H

b S

with

tryp

sin

(pro

teas

e –

cuts

he

mog

lobi

n in

to ~

30 p

eptid

es).

2.S

epar

ate

resu

lting

frag

men

ts b

y el

ectro

phor

esis

, and

th

en b

y ch

rom

atog

raph

y.3.

Trac

e th

e pe

ptid

e m

ap.

V. I

ngra

m (1

956)

Nat

ure

178:

792

.

Page 3: Important distinctionmcb.berkeley.edu/courses/mcb140/Syllabus/urnov_lectures/...1 1 MCB 140 12-4-06 Nosce te ipsum: the human genome Part II: genetics, diagnostics, and gene therapy

3

9M

CB

140

12-

4-06

V. I

ngra

m (1

956)

Nat

ure

178:

792

.10

MC

B 1

40 1

2-4-

06

“One

can

now

ans

wer

at l

east

par

tly th

e qu

estio

n pu

t ear

lier,

and

say

ther

e th

ere

is a

di

ffere

nce

in th

e am

ino-

acid

seq

uenc

e in

on

e sm

all p

art o

f one

of t

he p

olyp

eptid

e ch

ains

. Thi

s is

par

ticul

arly

inte

rest

ing

in v

iew

of

the

gene

tic e

vide

nce

that

the

form

atio

n of

hem

oglo

bin

S is

due

to a

mut

atio

n in

a

sing

le g

ene.

V. I

ngra

m (1

956)

Nat

ure

178:

792

.

11M

CB

140

12-

4-06

11.7

12M

CB

140

12-

4-06

SC

A1.

Fairl

y ho

mog

eneo

us g

enet

ic b

asis

–an

A-to

-T

trans

vers

ion

in th

e si

xth

codo

n of

the

HB

B g

ene

that

le

ads

to a

glu

→va

l sub

stitu

tion

(→R

FLP

!)2.

In N

orth

Am

eric

a, h

eter

ozyg

osity

for m

utan

t alle

le is

la

rgel

y as

ympt

omat

ic (s

ickl

e ce

ll tra

it), b

ecau

se

conc

entra

tion

of h

emog

lobi

n S

is n

ot h

igh

enou

gh fo

r th

e er

ythr

ocyt

es to

sic

kle.

3.In

are

as w

ith h

igh

inci

denc

e of

mal

aria

, the

fitn

ess

of

hete

rozy

gote

s is

gre

ater

than

of n

onca

rrie

rs o

r affe

cted

in

divi

dual

s (o

verd

omin

ance

) bec

ause

car

riers

are

re

lativ

ely

mal

aria

-res

ista

nt, e

xpla

inin

g th

e hi

gh

frequ

ency

of t

his

alle

le.

4.Th

erap

y –

hydr

oxyu

rea

(wak

es u

p em

bryo

nic

and

feta

l gl

obin

gen

es),

mor

phin

e fo

r the

pai

n, a

nd p

roph

ylac

tic

peni

cilli

n. “S

ickl

e ce

ll an

aem

ia. A

sim

ple

dise

ase

with

no

cur

e” (N

atur

e 19

89).

Page 4: Important distinctionmcb.berkeley.edu/courses/mcb140/Syllabus/urnov_lectures/...1 1 MCB 140 12-4-06 Nosce te ipsum: the human genome Part II: genetics, diagnostics, and gene therapy

4

13M

CB

140

12-

4-06

“Fun

ctio

nal c

loni

ng”

In th

e ca

se o

f alk

apto

nuria

, sic

kle

cell

anem

ia, a

nd b

lood

clo

tting

dis

orde

rs s

uch

as h

emop

hilia

, th

e di

seas

e ge

nes

is

iden

tifie

d ba

sed

on s

ome

bioc

hem

ical

or

othe

r def

ect e

xhib

ited

by th

e pa

tient

.W

hat i

f the

def

ect c

anno

t be

trace

d in

a

sim

ple

way

to a

bio

chem

ical

ph

enom

enon

?

14M

CB

140

12-

4-06

Cys

tic fi

bros

is

•M

ost c

omm

on m

onog

enic

aut

osom

al

hum

an g

enet

ic d

isor

der –

1 in

eve

ry 2

000

live

birth

s.•

q2=0

.05%

; q=2

.2%

; p=9

7.8%

; 2pq

=4%

car

riers

.•

Com

plex

dys

func

tion

of th

e lu

ngs

and

the

panc

reas

.

15M

CB

140

12-

4-06

Life

exp

ecta

ncy

of C

F pa

tient

s

16M

CB

140

12-

4-06

Map

ping

by

linka

ge(“

posi

tiona

l clo

ning

”)If

a gi

ven

mar

ker i

s lin

ked

(=is

on

the

sam

e ch

rom

osom

e as

) to

the

gene

mut

atio

ns in

w

hich

cau

se a

cer

tain

dis

ease

, the

n on

e sh

ould

be

able

to o

bser

ve c

oinh

erita

nce

of

som

e al

lelic

form

of t

hat m

arke

r to

the

occu

rrenc

e of

the

dise

ase.

“Coi

nher

itanc

e” =

occ

urre

nce

in g

enot

ype

of

two

loci

with

a fr

eque

ncy

high

er th

an

Men

del’s

sec

ond

law

allo

ws.

Page 5: Important distinctionmcb.berkeley.edu/courses/mcb140/Syllabus/urnov_lectures/...1 1 MCB 140 12-4-06 Nosce te ipsum: the human genome Part II: genetics, diagnostics, and gene therapy

5

17M

CB

140

12-

4-06

11.1

718

MC

B 1

40 1

2-4-

06

Men

del’s

sec

ond

law

19M

CB

140

12-

4-06

4.17

20M

CB

140

12-

4-06

Page 6: Important distinctionmcb.berkeley.edu/courses/mcb140/Syllabus/urnov_lectures/...1 1 MCB 140 12-4-06 Nosce te ipsum: the human genome Part II: genetics, diagnostics, and gene therapy

6

21M

CB

140

12-

4-06

Ver

y si

mpl

e an

d as

toni

shin

gly

influ

entia

l con

sequ

ence

of a

ll th

is s

tuff

Two

mar

kers

loca

ted

on d

iffer

ent

chro

mos

omes

will

segr

egat

e aw

ay fr

om

each

oth

er in

one

out

of t

wo

mei

oses

.

Two

mar

kers

that

are

on

the

sam

e ch

rom

osom

e w

ill te

nd to

sta

y to

geth

er.

22M

CB

140

12-

4-06

Fig.

1 N

olan

Nol

an e

t al.

Nat

. Gen

et. (

2000

). 25

: 440

.

a, N

anom

ouse

(Nan

o),

GE

NA

50. b

, Dom

inan

t sp

ottin

g (K

itW-3

9H),

GE

NA

133.

c, A

m

icro

phth

alm

ia m

utan

t, G

EN

A16

3. d

,e, B

atfa

ce, a

cr

anio

faci

al m

utan

t, G

EN

A12

3.

23M

CB

140

12-

4-06

Will

iam

Ern

est C

astle

–fo

unde

r of

mou

se g

enet

ics

1.In

bree

ding

as

a to

ol fo

r mak

ing

gene

tical

ly

unifo

rm s

train

s of

mic

e th

at a

re h

omoz

ygou

s fo

r ev

ery

alle

le in

the

geno

me.

2.B

roth

er-s

iste

r mat

ings

–m

akes

12.

5% o

f all

loci

in

the

geno

me

hom

ozyg

ous

(Cla

renc

e Li

ttle)

.

Afte

r 40

gene

ratio

ns o

f bro

ther

-sis

ter m

atin

g,

>99.

98%

of g

enom

e is

hom

ozyg

ous.

By

F 60,

mic

e ar

e co

nsid

ered

gen

etic

ally

iden

tical

to o

ne a

noth

er.

24M

CB

140

12-

4-06

11.1

2

Page 7: Important distinctionmcb.berkeley.edu/courses/mcb140/Syllabus/urnov_lectures/...1 1 MCB 140 12-4-06 Nosce te ipsum: the human genome Part II: genetics, diagnostics, and gene therapy

7

25M

CB

140

12-

4-06

A B

C D

A B

C D

E F

G H

E F

G H

I J

K

L

I J

K

L

1

2

3

♂ ♀

26M

CB

140

12-

4-06

A B

C D

A B

C D

E F

G H

E F

G H

I J

K

L

I J

K

L

1

2

3

♂ ♀

x

27M

CB

140

12-

4-06

A B

C D

A B

C D

E F

G H

E F

G H

I J

K

L

I J

K

L

♂ ♀

x

Xa

b c

d

a b

c d

e f

g

h

e f

g

h

i j

k

l

i j

k

l

♂ ♀

28M

CB

140

12-

4-06

A B

C D

a b

c

d

E F

G H

e f

g

h

I J

K

L

i j

k

l

♂ ♀

x

Xa

b c

d

a b

c d

e f

g

h

e f

g

h

i j

k

l

k l

m n

♂ ♀

Page 8: Important distinctionmcb.berkeley.edu/courses/mcb140/Syllabus/urnov_lectures/...1 1 MCB 140 12-4-06 Nosce te ipsum: the human genome Part II: genetics, diagnostics, and gene therapy

8

29M

CB

140

12-

4-06

A B

C D

a b

c

d

E F

G H

e f

g

h

I J

K

L

i j

k

l

♂ ♀

x

meiosis

Dur

ing

mei

osis

, the

re is

a 5

0% c

hanc

e th

at th

e m

utan

t gen

e w

ill s

epar

ate

from

al

l mar

kers

on

unlin

ked

chro

mos

omes

. Thi

s m

eans

that

ther

e is

an

equa

l lik

elih

ood

of fo

rmin

g a

gam

ete

“X E

” and

“X e

” –si

mila

rly, “

X J

” and

“X j.

On

the

othe

r han

d, th

e m

utan

t gen

e w

ill n

ot s

epar

ate

as fr

eque

ntly

from

m

arke

rs th

at li

e on

the

sam

e ch

rom

osom

e as

it d

oes.

In o

ther

wor

ds, t

he “X

B”

gam

ete

will

be

mor

e fre

quen

t tha

n th

e “X

b” g

amet

e. T

o id

entif

y,on

whi

ch

chro

mos

ome,

and

whe

re e

xact

ly, t

he m

utan

t gen

e lie

s, w

e ne

ed to

find

the

spec

ific

mar

ker t

hat t

he d

isea

se a

lway

s in

herit

s w

ith.

30M

CB

140

12-

4-06

A B

C D

a b

c

d

E F

G H

e f

g

h

I J

K

L

i j

k

l

♂ ♀

x

Xa

b c

d

a b

c d

e f

g

h

e f

g

h

i j

k

l

k l

m n

♂ ♀

31M

CB

140

12-

4-06

Fina

lly

Take

all

the

mut

ant c

hild

ren.

Gen

otyp

e th

em fo

r mar

kers

ove

r the

ent

ire

geno

me.

Find

the

“upp

erca

se m

arke

r” th

at o

ccur

s w

ith th

e hi

ghes

t fre

quen

cy (>

>>50

%) i

n th

e m

utan

t chi

ldre

n.

32M

CB

140

12-

4-06

A B

C D

a b

c

d

E F

G H

e f

g

h

I J

K

L

i j

k

l

♂ ♀

xx

Page 9: Important distinctionmcb.berkeley.edu/courses/mcb140/Syllabus/urnov_lectures/...1 1 MCB 140 12-4-06 Nosce te ipsum: the human genome Part II: genetics, diagnostics, and gene therapy

9

33M

CB

140

12-

4-06

34M

CB

140

12-

4-06

5.12

35M

CB

140

12-

4-06

Pro

blem

Hum

ans

are

not D

roso

phila

or m

ouse

.

To m

ap g

enet

ic d

ista

nce,

one

nee

ds to

“set

up

cro

sses

” with

kno

wn

arra

ngem

ents

of

geno

type

s.

36M

CB

140

12-

4-06

The

Pro

blem

of P

hase

In h

uman

ped

igre

es, y

ou c

anno

t “se

t up

a cr

oss”

th

e w

ay y

ou w

ant t

o! E

ven

in a

sim

ple

cros

s:♂

AaBb

×♀

aabb

… y

ou re

ally

nee

d to

kno

w w

heth

er D

ad w

as

AB

/ab

or A

b/aB

in o

rder

to c

alcu

late

map

di

stan

ces

(you

nee

d to

tell

whi

ch c

hild

is

reco

mbi

nant

and

whi

ch o

ne is

n’t!!

!)

AB

ab

Ab

aB

OR

Page 10: Important distinctionmcb.berkeley.edu/courses/mcb140/Syllabus/urnov_lectures/...1 1 MCB 140 12-4-06 Nosce te ipsum: the human genome Part II: genetics, diagnostics, and gene therapy

10

37M

CB

140

12-

4-06

11.1

838

MC

B 1

40 1

2-4-

06

Lod

scor

es a

nd m

appi

ng b

y lin

kage

Sol

utio

n: c

alcu

late

loga

rithm

of t

he o

dds

(lod)

that

the

pedi

gree

obs

erve

d is

due

to li

nkag

e.

For a

ny g

iven

trai

t (di

seas

e) a

nd a

ny g

iven

mar

ker b

eing

tra

cked

in th

e pe

digr

ee, t

he L

od s

core

is th

e lo

g 10

of th

e fo

llow

ing

ratio

:pr

obab

ility

that

this

ped

igre

e w

ould

be

obse

rved

if th

e tw

o lo

ci a

re li

nked

, and

are

sep

arat

ed b

y a

certa

in g

enet

ic

dist

ance

DIV

IDE

D b

y pr

obab

ility

this

ped

igre

e w

ould

be

obse

rved

if th

e tw

o lo

ci w

ere

unlin

ked.

Two

loci

are

link

ed if

the

lod

scor

e >

3B

y th

e w

ay –

a lo

garit

hm is

take

n so

that

we

can

add

lod

scor

es o

btai

ned

from

diff

eren

t fam

ilies

!!

39M

CB

140

12-

4-06

p. 3

92-3

9340

MC

B 1

40 1

2-4-

06

Whi

te e

t al (

1985

) Nat

ure

318:

382

.A

RFL

P li

nked

to C

F!!!

–“m

iddl

e th

ird o

f 7q,

nea

r met

Page 11: Important distinctionmcb.berkeley.edu/courses/mcb140/Syllabus/urnov_lectures/...1 1 MCB 140 12-4-06 Nosce te ipsum: the human genome Part II: genetics, diagnostics, and gene therapy

11

41M

CB

140

12-

4-06

Find

ing

the

CF

gene

•Li

nkag

e an

alys

is p

lace

d th

e C

F ge

ne in

a

rath

er la

rge

(1.5

Mb)

frag

men

t of

chro

mos

ome

7 (n

ext t

o m

et)

•“J

umpi

ng a

nd w

alki

ng” –

Rom

men

s et

al

(Col

lins)

Sci

ence

245

: 105

9 (1

989)

.

42M

CB

140

12-

4-06

43M

CB

140

12-

4-06

CFT

R

•La

rge

gene

(250

kb)

•La

rge

prot

ein

(1,4

80 a

a)•

cAM

P-re

gula

ted

chlo

ride

chan

nel

•70

% o

f mut

atio

ns –

∆phe

508

(pro

tein

st

uck

in th

e E

R)

Bre

nnan

and

Ged

des

(200

2) C

urr.

Opi

n. In

fect

. Dis

. 15:

175

-182

.44

MC

B 1

40 1

2-4-

0611

.22

Page 12: Important distinctionmcb.berkeley.edu/courses/mcb140/Syllabus/urnov_lectures/...1 1 MCB 140 12-4-06 Nosce te ipsum: the human genome Part II: genetics, diagnostics, and gene therapy

12

45M

CB

140

12-

4-06

11.2

246

MC

B 1

40 1

2-4-

06

Gen

e th

erap

y fo

r CF?

2002

:“S

ince

the

clon

ing

of th

e cy

stic

fibr

osis

gen

e (C

FTR

) in

1989

, 18

clin

ical

tria

ls h

ave

been

car

ried

…. M

ost t

rials

dem

onst

rate

d pr

oof-o

f-prin

cipl

e fo

r ge

ne tr

ansf

er to

the

airw

ay. H

owev

er, g

ene

trans

fer e

ffici

ency

… w

as lo

w, a

nd m

ost l

ikel

y in

suffi

cien

t to

achi

eve

clin

ical

ben

efit.

A m

ajor

func

tion

of th

e ai

rway

epi

thel

ium

is to

pr

even

t upt

ake

of fo

reig

n m

ater

ials

, inc

ludi

ng g

ene

trans

fer a

gent

s.”

Qua

si-s

ucce

ss –

rela

tive

of H

IV in

an

Ebo

la c

oat!

Grie

senb

ach

et a

l. (2

002)

Gen

e Th

er. 9

: 134

4.

47M

CB

140

12-

4-06

48M

CB

140

12-

4-06

The

“kno

ckou

t” m

ouse

A m

ouse

gen

otyp

ical

ly u

nifo

rm a

nd

hom

ozyg

ous

for a

n am

orph

ic (f

ull n

ull)

alle

le

of a

gen

e of

cho

ice.

Page 13: Important distinctionmcb.berkeley.edu/courses/mcb140/Syllabus/urnov_lectures/...1 1 MCB 140 12-4-06 Nosce te ipsum: the human genome Part II: genetics, diagnostics, and gene therapy

13

49M

CB

140

12-

4-06

Em

bryo

nic

stem

cel

ls

50M

CB

140

12-

4-06

Ann

u. R

ev. C

ell D

ev. B

iol.

2001

. 17:

435-

462.

EM

BR

YO

-DER

IVED

STE

M C

ELLS

: Of M

ice

and

Men

A

ustin

G. S

mith

51M

CB

140

12-

4-06

52M

CB

140

12-

4-06

Pos

itive

-neg

ativ

e se

lect

ion

(Mar

io C

apec

chi,

1989

)N

on-H

R e

vent

s ar

e M

AS

SIV

ELY

mor

e fre

quen

t tha

n H

R e

vent

s.↓

Two

sequ

entia

l sel

ectio

n ev

ents

to e

limin

ate

all c

ells

that

und

erw

ent n

on-H

R o

r no

reco

mbi

natio

n at

all,

and

PR

ES

ER

VE

thos

e ce

lls th

at u

nder

wen

t HR

.

“Tar

getin

g co

nstru

ct”

Page 14: Important distinctionmcb.berkeley.edu/courses/mcb140/Syllabus/urnov_lectures/...1 1 MCB 140 12-4-06 Nosce te ipsum: the human genome Part II: genetics, diagnostics, and gene therapy

14

53M

CB

140

12-

4-06

54M

CB

140

12-

4-06

55M

CB

140

12-

4-06

56M

CB

140

12-

4-06

Page 15: Important distinctionmcb.berkeley.edu/courses/mcb140/Syllabus/urnov_lectures/...1 1 MCB 140 12-4-06 Nosce te ipsum: the human genome Part II: genetics, diagnostics, and gene therapy

15

57M

CB

140

12-

4-06

58M

CB

140

12-

4-06

Mou

se m

odel

?

p. 8

57: “

Ani

mal

s ho

moz

ygou

s fo

r the

CFT

R

knoc

kout

alle

le d

ispl

ay a

mut

ant

phen

otyp

e th

at is

ver

y si

mila

r to

that

ex

pres

sed

by h

uman

s su

fferin

g fro

m c

ystic

fib

rosi

s.”

I beg

you

r par

don?

59M

CB

140

12-

4-06

And

now

, the

trut

h

“The

airw

ays

of C

F m

ice

are

of o

bvio

us in

tere

st to

in

vest

igat

ors

beca

use

~95%

of t

he m

orbi

dity

and

m

orta

lity

in C

F hu

man

s is

due

to p

ulm

onar

y m

anife

stat

ions

of t

he d

isea

se. …

In th

e C

F pa

tient

, a c

onsi

sten

t fin

ding

in th

e ai

rway

s is

m

ucus

plu

ggin

g w

ith b

acte

rial i

nfec

tion.

…In

all

CF

mou

se m

odel

s ex

amin

ed, v

irtua

lly n

orm

al

lung

his

tolo

gy a

nd a

bsen

ce o

f muc

us p

lugg

ing

are

cons

iste

nt fi

ndin

gs (3

6, 3

9, 7

0, 7

8, 9

2, 1

03,

114,

119

).”

Gru

bb a

nd B

ouch

er (1

999)

Phy

s. R

ev. 7

9: 1

93-2

14.

60M

CB

140

12-

4-06

Page 16: Important distinctionmcb.berkeley.edu/courses/mcb140/Syllabus/urnov_lectures/...1 1 MCB 140 12-4-06 Nosce te ipsum: the human genome Part II: genetics, diagnostics, and gene therapy

16

61M

CB

140

12-

4-06

A re

mar

kabl

e ex

ampl

e of

a

phen

otyp

e in

a k

nock

out m

ouse

A D

efec

t in

Nur

turin

g in

Mic

e La

ckin

g th

e Im

med

iate

Ear

ly G

ene fosB

Bro

wn

et a

l.C

ell,

Vol

. 86,

297

–309

, Jul

y, 1

996

62M

CB

140

12-

4-06

63M

CB

140

12-

4-06

64M

CB

140

12-

4-06

Page 17: Important distinctionmcb.berkeley.edu/courses/mcb140/Syllabus/urnov_lectures/...1 1 MCB 140 12-4-06 Nosce te ipsum: the human genome Part II: genetics, diagnostics, and gene therapy

17

65M

CB

140

12-

4-06

“Car

rier s

cree

ning

for c

ystic

fibr

osis

, Gau

cher

dis

ease

, and

Ta

y-S

achs

dis

ease

in th

e A

shke

nazi

Jew

ish

popu

latio

n: th

e fir

st 1

000

case

s at

New

Yor

k U

nive

rsity

Med

ical

Cen

ter”

By

late

199

3, th

e ge

nes

for c

ystic

fibr

osis

and

Gau

cher

dis

ease

and

the

mut

atio

ns c

omm

on a

mon

g A

shke

nazi

Jew

s ha

d be

en id

entif

ied.

In

resp

onse

to th

ese

adva

nces

, het

eroz

ygot

e sc

reen

ing

for c

ystic

fibr

osis

an

d G

auch

er d

isea

se w

as a

dded

to th

e m

ore

than

20-

year

-old

Tay

-S

achs

dis

ease

scr

eeni

ng p

rogr

am a

t New

Yor

k U

nive

rsity

Med

ical

C

ente

r, N

ew Y

ork,

NY.

… P

atie

nts

and

thei

r ref

errin

g ph

ysic

ians

wer

e in

form

ed a

bout

the

new

car

rier t

ests

. At t

he ti

me

of s

cree

ning

, pat

ient

s co

uld

choo

se th

eir t

ests

(hex

osam

inid

ase

A b

y en

zym

e an

alys

is fo

r Ta

y-S

achs

dis

ease

or m

utat

ion

anal

ysis

for c

ystic

fibr

osis

and

Gau

cher

di

seas

e). …

The

maj

ority

of A

shke

nazi

Jew

ish

patie

nts

chos

e to

hav

e te

stin

g fo

r all

3 di

seas

es. I

f the

y pr

evio

usly

und

erw

ent s

cree

ning

for

Tay-

Sac

hs d

isea

se, t

hen

they

cho

se to

und

ergo

test

ing

for c

ystic

fib

rosi

s an

d G

auch

er d

isea

se. A

ll ca

rrier

cou

ples

for e

ach

of th

ese

dise

ases

wen

t on

to h

ave

pren

atal

test

ing.

All

mix

ed-m

arria

ge c

oupl

es

in w

hom

the

Jew

ish

partn

er w

as fo

und

to b

e a

carr

ier f

or G

auch

erdi

seas

e ch

ose

to h

ave

pren

atal

dia

gnos

is. O

ne fe

tus

was

iden

tifie

d as

ha

ving

cys

tic fi

bros

is. S

ince

the

prog

ram

was

initi

ated

, no

Ash

kena

zi

Jew

ish

baby

has

bee

n bo

rn w

ith a

ny o

f the

se d

isea

ses

at N

ew Y

ork

Uni

vers

ity M

edic

al C

ente

r.

Kro

nn e

t al.

(199

8) A

rch.

Inte

rn. M

ed. 1

58: 7

77.

66M

CB

140

12-

4-06

67M

CB

140

12-

4-06

68M

CB

140

12-

4-06